Frequently Asked Questions
Our FAQ section is designed to provide clear and useful information about Nivian Life Sciences, our focus areas, product divisions.
Nivian Life Sciences Pvt. Ltd. is a pharmaceutical healthcare company focused on Assisted Reproductive Technology (ART), IVF, and Women's Health. The company aims to provide quality-focused pharmaceutical solutions while building long-term relationships with healthcare professionals and partners.
Nivian's primary focus areas are Assisted Reproductive Technology (ART), IVF, and Women's Health. The company has developed dedicated product divisions to address these specialised areas of pharmaceutical healthcare.
Nivian Life Sciences is committed to the highest standards of pharmaceutical quality and safety. Our products are manufactured through WHO-GMP certified facilities, combining trusted contract manufacturing partnerships with in-house indigenous production capabilities. Every product undergoes rigorous quality checks at each stage from formulation to packaging ensuring full compliance with applicable Indian regulatory and pharmacopoeial standards.Â
Nivian has a Pan-India presence, covering more than 15 states and Union Territories, supported by a dedicated field force working closely with IVF specialists and fertility centres nationwide. Clinics and hospitals looking for regional availability or stockist partnerships can connect directly with our sales team.Â
The current FEMIvian™ portfolio includes Clindavian™, Dydrovian™, and Ferrovian™. These products represent Nivian's focus on developing a specialised portfolio for Women's Health. Product information should always be reviewed according to the approved product documentation.
Nivian's IVF portfolio comprises a well-established range of formulations spanning gonadotropins, GnRH analogues, hormonal support, and adjunct fertility therapies each developed to meet stringent Indian regulatory standards for safety, quality, and efficacy. Â
Yes. Nivian's portfolio is purpose-built to support nearly every stage of the ART journeyfrom ovarian stimulation and trigger, through luteal phase support, to adjunct and women's health therapies. This allows fertility specialists to rely on a single, dedicated partner across the entire treatment continuum, rather than sourcing from multiple general pharmaceutical companies.Â
Yes. Nivian maintains an active presence at leading fertility conferences and forums including ISAR, Fertivision, ESHRE, ASPIRE, and IFS, among others and supports ongoing clinical education through CMEs and scientific webinars. We remain committed to collaborative engagement with clinicians and institutions on relevant clinical initiatives that advance the field of reproductive medicine.Â
Nivian's portfolio is organised into two focused therapeutic divisions:Â
- ARTvian — dedicated to IVF and Assisted Reproductive Technology therapies across the treatment cycleÂ
- Femivian — focused on women's health solutions beyond the IVF cycleÂ
This structure allows each therapeutic area to be addressed with clinical precision, while remaining under Nivian's unified standard of quality and service.Â
Nivian is committed to staying informed about research, innovation, and emerging developments in ART and Women's Health. Its Knowledge Centre highlights relevant scientific research and developments in areas such as embryo implantation, immunomodulation, uterine physiology, and Artificial Intelligence in ART.
For product-related medical queries, safety concerns, or adverse event reporting, doctors can reach our Medical Affairs team at @nivianlifesciences.com. All queries and reports are handled promptly and in strict accordance with pharmacovigilance requirements.Â

